You might be right about the cr but that doesn’t invalidate this. It’s not a puff piece. It’s a real breakthrough. Interventional radiologists are hungry beasts and given their departments diagnose the tumours and talk to the oncologist and surgeons in the meetings this will make a huge difference in the uptake. They basically made the market for Sirtex.
Ann: OncoSil onboards first patient in PANCOSIL Clinical Trial, page-5
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.010(0.86%) |
Mkt cap ! $21.74M | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.17 | $1.14 | $80.47K | 69.48K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2150 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 7380 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| OSL (ASX) Chart |